Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components
Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components
复制标题
DOI:
10.1016/j.micinf.2004.02.011
复制
发表时间:
2004-05-01
影响因子:
5.8
通讯作者:
Kawaoka, Y
中科院分区:
文献类型:
--
作者:
Horimoto, T;Iwatsuki-Horimoto, K;Kawaoka, Y
A licensed live attenuated influenza vaccine is available as a trivalent mixture of types A (H1N1 and H3N2) and B vaccine viruses. Thus, interference among these viruses could restrict their replication, affecting vaccine efficacy. One approach to overcoming this potential problem is to use a chimeric virus possessing type B hemagglutinin (HA) and neuraminidase (NA) in a type A vaccine virus background. We previously generated a type A virus possessing a chimeric HA in which the entire ectodomain of the type A HA molecule was replaced with that of the type B HA, and showed that this virus protected mice from challenge by a wild-type B virus. In the study described here, we generated type A/B chimeric viruses carrying not only the chimeric (A/B) HA, but also the full-length type B NA instead of the type A NA, resulting in (A/B) HA/NA chimeric viruses possessing type B HA and NA ectodomains in the background of a type A virus. These (A/B) HA/NA chimeric viruses were attenuated in both cell culture and mice as compared with the wild-type A virus. Our findings may allow an effective live influenza vaccine to be produced from a single master strain, providing a model for the design of future live influenza vaccines. (C) 2004 Elsevier SAS. All rights reserved.